Market Overview The viral clearance market faces unique challenges and opportunities in gene therapy and viral vector manufacturing where the therapeutic product itself is a virus or derived from viral components, requiring sophisticated clearance strategies that distinguish between therapeutic vectors and potential adventitious or replication-competent contaminants. As adeno-associated virus,...